---
layout: default
title: Potassium Iodide
description: "Potassium Iodide çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 2 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 134
evidence_level: L4
indication_count: 2
---

# Potassium Iodide

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>2</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Potassium Iodide (ç¢˜åŒ–é‰€) - è—¥å¸«è©•ä¼°å ±å‘Š

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Potassium Iodide å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
ç¢˜åŒ–é‰€æ˜¯ä¸€ç¨®å…·æœ‰ç¥›ç—°ã€æŠ—çœŸèŒåŠç”²ç‹€è…ºä¿è­·ä½œç”¨çš„è—¥ç‰©,TxGNNé æ¸¬å…¶å¯ç”¨æ–¼é¼»è…”ç–¾ç—…æ²»ç™‚,å·²æœ‰æ–‡ç»è­‰æ“šæ”¯æŒå…¶å°çœŸèŒæ€§é¼»ç«‡ç‚çš„ç™‚æ•ˆã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Potassium Iodide (ç¢˜åŒ–é‰€) |
| DrugBank ID | DB06715 |
| å°ç£å“ç‰Œå | ç¢˜åŒ–é‰€ã€æ¿ƒç¢˜é…Šã€ç¢˜æ¥Šé…¸å¤–ç”¨æ¶²åŠ‘ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | ç¥›ç—°ã€çš®è†šæ¶ˆæ¯’ã€ç”²ç‹€è…ºè…«é é˜²ã€çµ²ç‹€èŒæ„ŸæŸ“ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | pharyngitisã€nasal cavity disease |
| æœ€é«˜è­‰æ“šç­‰ç´š | L3 (è§€å¯Ÿæ€§ç ”ç©¶/ç—…ä¾‹å ±å‘Š) |
| è‡¨åºŠè©¦é©—æ•¸ | 0é … |
| æ–‡ç»æ”¯æŒ | 4ç¯‡ (é¼»è…”çœŸèŒæ„ŸæŸ“) |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. nasal cavity disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.95%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>### é¼»è…”ç–¾ç—…é æ¸¬åˆ†æ (TxGNN Score: 0.9995, Rank: 1593)</p>

<ol>
<li><strong>æŠ—çœŸèŒæ´»æ€§</strong>: ç¢˜åŒ–é‰€å…·æœ‰å·²çŸ¥çš„æŠ—çœŸèŒæ´»æ€§,ç‰¹åˆ¥æ˜¯å°å­¢å­çµ²èŒç—…å’Œæ¥åˆèŒç—…</li>
<li><strong>é»è†œä½œç”¨</strong>: ç¢˜é›¢å­å¯ä¿ƒé€²é»æ¶²åˆ†æ³Œå’Œæ¸…é™¤</li>
<li><strong>å…ç–«èª¿ç¯€</strong>: å¯èƒ½å…·æœ‰å¢å¼·å±€éƒ¨å…ç–«åæ‡‰çš„ä½œç”¨</li>
<li><strong>æ­·å²æ‡‰ç”¨</strong>: å‚³çµ±ä¸Šç”¨æ–¼æ²»ç™‚æ·±éƒ¨çœŸèŒæ„ŸæŸ“</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34902797/" target="_blank">34902797</a></td><td>2022</td><td>Article</td><td>Journal de mycologie medicale</td><td>Successful potassium iodide treatment for rhinofacial pythiosis in sheep.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39576399/" target="_blank">39576399</a></td><td>2024</td><td>Article</td><td>Veterinary research communicat</td><td>Treatment of mycotic rhinitis caused by aspergillus fumigatus in a quarter horse...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10976304/" target="_blank">10976304</a></td><td>2000</td><td>Article</td><td>Journal of the American Veteri</td><td>Pseudallescheria boydii infection of the nasal cavity of a horse.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7997795/" target="_blank">7997795</a></td><td>1994</td><td>Article</td><td>Revista do Instituto de Medici</td><td>[Nasofacial zygomycosis. Report of a case of Para state, Brazil].</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. acute laryngopharyngitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.95%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

### æœ‰æ•ˆè¨±å¯è­‰

| è¨±å¯è­‰å­—è™Ÿ | å“å | é©æ‡‰ç—‡ | æ•ˆæœŸ |
|------------|------|--------|------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬027470è™Ÿ | ç¢˜åŒ–é‰€ | ç¥›ç—°è—¥ | 2028/07/12 |
| è¡›ç½²è—¥è£½å­—ç¬¬033308è™Ÿ | æ¿ƒç¢˜é…Š | çš®è†šæ®ºèŒæ¶ˆæ¯’ | 2028/05/25 |
| è¡›ç½²è—¥è£½å­—ç¬¬044330è™Ÿ | ç¢˜æ¥Šé…¸å¤–ç”¨æ¶²åŠ‘ | çµ²ç‹€èŒæ„ŸæŸ“ | 2026/03/09 |

### æŒè­‰å…¬å¸
- å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸
- æ–°å–œåœ‹éš›ä¼æ¥­è‚¡ä»½æœ‰é™å…¬å¸
- å¯¶é½¡å¯ŒéŒ¦ç”ŸæŠ€è‚¡ä»½æœ‰é™å…¬å¸

## å®‰å…¨æ€§è€ƒé‡

### å·²çŸ¥å®‰å…¨æ€§è³‡è¨Š

1. **ç”²ç‹€è…ºåŠŸèƒ½å½±éŸ¿**: é•·æœŸé«˜åŠ‘é‡å¯èƒ½å°è‡´ç”²ç‹€è…ºåŠŸèƒ½ç•°å¸¸
2. **ç¢˜éæ•**: å°ç¢˜éæ•è€…ç¦ç”¨
3. **å¦Šå¨ å“ºä¹³**: å¯ç©¿é€èƒç›¤,éœ€è¬¹æ…ä½¿ç”¨
4. **è…åŠŸèƒ½**: è…åŠŸèƒ½ä¸å…¨è€…éœ€èª¿æ•´åŠ‘é‡

### è—¥ç‰©äº¤äº’ä½œç”¨ (é‡è¦)

ç¢˜åŒ–é‰€æœ‰å¤šé …é‡è¦è—¥ç‰©äº¤äº’ä½œç”¨,éœ€ç‰¹åˆ¥æ³¨æ„:

**Major (ä¸»è¦) äº¤äº’ä½œç”¨**:
| äº¤äº’è—¥ç‰© | æ©Ÿåˆ¶/é¢¨éšª |
|----------|-----------|
| ACEæŠ‘åˆ¶åŠ‘ (Benazepril, Captopril, Enalaprilç­‰) | å¢åŠ é«˜è¡€é‰€é¢¨éšª |
| ARBé¡ (Losartan, Valsartan, Irbesartanç­‰) | å¢åŠ é«˜è¡€é‰€é¢¨éšª |
| Eplerenone | åš´é‡é«˜è¡€é‰€é¢¨éšª |
| Trimethoprim | é«˜è¡€é‰€é¢¨éšª |

**Moderate (ä¸­ç­‰) äº¤äº’ä½œç”¨**:
| äº¤äº’è—¥ç‰© | æ©Ÿåˆ¶/é¢¨éšª |
|----------|-----------|
| NSAIDs (Ibuprofen, Diclofenac, Naproxenç­‰) | å¯èƒ½å¢åŠ è¡€é‰€ |
| Lithium | å¯èƒ½å½±éŸ¿ç”²ç‹€è…ºåŠŸèƒ½ |
| I-131, I-123 | å¹²æ“¾æ”¾å°„ç¢˜æ”å– |
| Aliskiren | å¢åŠ é«˜è¡€é‰€é¢¨éšª |


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**ç”²ç‹€è…ºæ©Ÿèƒ½äº¢é€²** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šThe use of iodide salts has been associated with the exacerbation or precipitation of hyperthyroidism in patients previously euthyroid...

**Heart Diseases** ğŸŸ¡ Moderate
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**Dermatitis Herpetiformis** ğŸŸ¡ Moderate
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**Vasculitis** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šPeople who are allergic to iodide or have hypocomplementemic vasculitis should not take potassium iodide...

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### æ•´é«”è©•ä¼°

| è©•ä¼°é …ç›® | é¼»è…”ç–¾ç—… | æ€¥æ€§å–‰å’½ç‚ |
|----------|----------|------------|
| è­‰æ“šç­‰ç´š | L3 (ç—…ä¾‹å ±å‘Š) | L5 (åƒ…é æ¸¬) |
| æ©Ÿåˆ¶åˆç†æ€§ | é«˜ (æŠ—çœŸèŒ) | ä¸­ (ç¥›ç—°) |
| è‡¨åºŠå¯è¡Œæ€§ | ä¸­ (é™çœŸèŒæ€§) | ä½ |
| å»ºè­°å„ªå…ˆé †åº | ä¸­ | ä½ |

### å»ºè­°

**é¼»è…”çœŸèŒæ„ŸæŸ“**:
1. **é©ç”¨æ—ç¾¤**: çœŸèŒæ€§é¼»ç«‡ç‚,ç‰¹åˆ¥æ˜¯æ¥åˆèŒç—…ã€è…é»´ç—…
2. **åˆä½µæ²»ç™‚**: å»ºè­°èˆ‡å…¶ä»–æŠ—çœŸèŒè—¥ç‰©(å¦‚itraconazole)åˆä½µä½¿ç”¨
3. **é€²ä¸€æ­¥ç ”ç©¶**: éœ€è¦å‰ç»æ€§è‡¨åºŠè©¦é©—è©•ä¼°ç™‚æ•ˆå’Œå®‰å…¨æ€§
4. **è‡¨åºŠå®šä½**: ä½œç‚ºé›£æ²»æ€§çœŸèŒæ€§é¼»éƒ¨æ„ŸæŸ“çš„è¼”åŠ©æ²»ç™‚é¸é …

**æ€¥æ€§å–‰å’½ç‚**:
- ç¼ºä¹ç›´æ¥è­‰æ“šæ”¯æŒ
- ä¸å»ºè­°ä½œç‚ºä¸»è¦æ²»ç™‚é¸é …

### ç”¨è—¥ç›£æ¸¬å»ºè­°

1. **ç”²ç‹€è…ºåŠŸèƒ½**: é•·æœŸä½¿ç”¨éœ€å®šæœŸç›£æ¸¬TSH
2. **è¡€é‰€æ¿ƒåº¦**: ç‰¹åˆ¥æ˜¯åˆä½µä½¿ç”¨é«˜è¡€é‰€é¢¨éšªè—¥ç‰©æ™‚
3. **è…åŠŸèƒ½**: å®šæœŸç›£æ¸¬è‚Œé…æ¸…é™¤ç‡

### é™åˆ¶èªªæ˜

- é¼»è…”çœŸèŒæ„ŸæŸ“çš„è­‰æ“šä¸»è¦ä¾†è‡ªç—…ä¾‹å ±å‘Š
- ç¼ºä¹å¤§è¦æ¨¡éš¨æ©Ÿå°ç…§è©¦é©—
- ç¸é†«ç ”ç©¶çµæœä¸èƒ½ç›´æ¥å¤–æ¨è‡³äººé¡

---
*å ±å‘Šç”¢ç”Ÿæ—¥æœŸ: 2026-02-11*
*è³‡æ–™ä¾†æº: TxGNNé æ¸¬ã€ClinicalTrials.govã€PubMedã€å°ç£é£Ÿå“è—¥ç‰©ç®¡ç†ç½²ã€DDInter*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Pemetrexed]({{ "/drugs/pemetrexed/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Povidone]({{ "/drugs/povidone/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Denosumab]({{ "/drugs/denosumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Atracurium Besylate]({{ "/drugs/atracurium_besylate/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Sacituzumab Govitecan]({{ "/drugs/sacituzumab_govitecan/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Potassium Iodideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/potassium_iodide/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_potassium_iodide,
  title = {Potassium Iodideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/potassium_iodide/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
